Additionally, long-term medical costs of the morbidities that develop over years after gene therapy is known to be a highly significant contributor to affordability.
1
—
—
Additionally, long-term medical costs of the morbidities that develop over years after gene therapy is known to be a highly significant contributor to affordability.